Lion TCR Competitors and Similar CompaniesClear all
Lion TCR's competitors and similar companies include Viralytics, MABION, Adagene and UT Health San Antonio MD Anderson Cancer Center.
 Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. |  Viralytics Viralytics is a biotechnology company focused on the development and commercialization of oncology immunotherapies. |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Adagene Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy. |  UT Health San Antonio MD Anderson Cancer Center UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care. | |
Founding Date | Founding Date N/A | Founding Date 2006 | Founding Date 2007 | Founding Date 2012 | Founding Date N/A |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG | Locations Sydney, AU HQ | Locations Konstantynów Łódzki, PL HQ | Locations Suzhou, CN HQ San Diego, US San Francisco, US | Locations San Antonio, US HQ |
Employees | Employees N/A | Employees N/A | Employees 95 | Employees 174 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 21.7 m | Valuation ($) 137.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) zł151.7m (FY, 2023) | Revenue (est.) $103k (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods zł29.9m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit zł122.3m (FY, 2023) | Gross profit $103k (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income zł41.3m (FY, 2023) | Net income ($33.4m) (FY, 2024) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 20m | Total funding raised $ 27m | Total funding raised N/A | Total funding raised $ 155m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Viralytics
HQ
Sydney, AU
Viralytics is a biotechnology company focused on the development and commercialization of oncology immunotherapies.
View companyMABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companyAdagene
HQ
Suzhou, CN
Employees
174
Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.
View companyUT Health San Antonio MD Anderson Cancer Center
HQ
San Antonio, US
UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care.
View company